NMR INVESTOR ALERT: Bronstein, Gewirtz And Grossman, LLC Announces An Investigation Into Nomura Holdings Inc ADR And Encourages Investors To Contact The Firm
Date
10/2/2024 4:16:04 PM
(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nomura Holdings Inc ADR (“Nomura” or“the Company”) (NYSE: NMR). Investors who purchased Nomura securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NMR .
Investigation Details
On September 30, 2024, media outlets reported that Nomura was excluded as lead manager for several yen bond deals after an investigation by Japan's securities watchdog into suspected market manipulation in government bond futures found rule violations by Nomura. On this news, Nomura's American depositary receipt (“ADR”) price fell $0.26 per ADR, or 4.74%, to close at $5.22 per ADR on September 30, 2024.
What's Next?
If you are aware of any facts relating to this investigation or purchased Nomura securities, you can assist this investigation by visiting the firm's site: . You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | ...
MENAFN02102024004107003653ID1108740988
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.